Perioperative Management of Anticoagulation

被引：9
作者：
Guha, Daipayan [1 ]
Macdonald, R. Loch [1 ,2 ]
机构：
[1] Univ Toronto, Toronto Western Hosp, Dept Surg, Div Neurosurg, 399 Bathurst St,West Wing,4th Floor, Toronto, ON M5T 2S8, Canada
[2] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr Biomed Sci, Div Neurosurg, 30 Bond St, Toronto, ON M5B 1W8, Canada
来源：
NEUROSURGERY CLINICS OF NORTH AMERICA | 2017年 / 28卷 / 02期
关键词：
Subdural hematoma; Anticoagulation; Antiplatelet; Bleeding; Thrombosis; PROTHROMBIN COMPLEX CONCENTRATE; CHRONIC SUBDURAL-HEMATOMA; IMPROVES PLATELET ACTIVITY; FRESH-FROZEN PLASMA; ATRIAL-FIBRILLATION; INTRACRANIAL HEMORRHAGE; TRANEXAMIC ACID; RISK-FACTORS; INDEPENDENT PREDICTORS; ANTIPLATELET THERAPY;
D O I：
10.1016/j.nec.2016.11.011
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
Antiplatelet and anticoagulant drugs (antithrombotics) predispose to acute and chronic subdural hematomas. Patients on these drugs are at higher likelihood of presenting with larger hematomas and more severe neurologic deficits. Standard neurosurgical and neurocritical care of subdural hematomas involves reversal of antithrombosis preoperatively, whereas reversing antiplatelet drugs is less clear. This article highlights the spectrum of antithrombotic agents in common use, their mechanisms of action, and strategies for reversal.
引用
收藏
页码：287 / +
页数：10
相关论文
共 62 条
  • [11] The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma
    Forster, M. T.
    Mathe, A. K.
    Senft, C.
    Scharrer, I.
    Seifert, V.
    Gerlach, R.
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (08) : 975 - 979
  • [12] Frontera JA, 2016, NEUROCRIT CARE, V24, P6, DOI 10.1007/s12028-015-0222-x
  • [13] The CVD paradox: mortality vs prevalence
    Fuster, Valentin
    Mearns, Bryony M.
    [J]. NATURE REVIEWS CARDIOLOGY, 2009, 6 (11) : 669 - 669
  • [14] Clinical classification schemes for predicting hemorrhage: Results from the National Registry of Atrial Fibrillation (NRAF)
    Gage, BF
    Yan, Y
    Milligan, PE
    Waterman, AD
    Culverhouse, R
    Rich, MW
    Radford, MJ
    [J]. AMERICAN HEART JOURNAL, 2006, 151 (03) : 713 - 719
  • [15] Safety, tolerability, and efficacy of idarucizumab for the reversal of the anticoagulant effect of dabigatran in healthy male volunteers: a randomised, placebo-controlled, double-blind phase 1 trial
    Glund, Stephan
    Stangier, Joachim
    Schmohl, Michael
    Gansser, Dietmar
    Norris, Stephen
    van Ryn, Joanne
    Lang, Benjamin
    Ramael, Steven
    Moschetti, Viktoria
    Gruenenfelder, Fredrik
    Reilly, Paul
    Kreuzer, Joerg
    [J]. LANCET, 2015, 386 (9994) : 680 - 690
  • [16] Prevalence of diagnosed atrial fibrillation in adults - National implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study
    Go, AS
    Hylek, EM
    Phillips, KA
    Chang, YC
    Henault, LE
    Selby, JV
    Singer, DE
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (18): : 2370 - 2375
  • [17] Inefficacy of Platelet Transfusion to Reverse Ticagrelor
    Godier, Anne
    Taylor, Guillaume
    Gaussem, Pascale
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (02) : 196 - 197
  • [18] Warfarin and chronic subdural haematomas
    Gonugunta, V
    Buxton, N
    [J]. BRITISH JOURNAL OF NEUROSURGERY, 2001, 15 (06) : 514 - 517
  • [19] Modeling the Cost-Effectiveness of Prothrombin Complex Concentrate Compared With Fresh Frozen Plasma in Emergency Warfarin Reversal in the United Kingdom
    Guest, Julian F.
    Watson, Henry G.
    Limaye, Sameer
    [J]. CLINICAL THERAPEUTICS, 2010, 32 (14) : 2478 - 2493
  • [20] Timing of the resumption of antithrombotic agents following surgical evacuation of chronic subdural hematomas: a retrospective cohort study
    Guha, Daipayan
    Coyne, Shona
    Macdonald, R. Loch
    [J]. JOURNAL OF NEUROSURGERY, 2016, 124 (03) : 750 - 759
1234567